Vincere Biosciences Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Vincere Biosciences Inc. - overview
Established
2018
Location
Cambridge, MA, US
Primary Industry
Biotechnology
About
Based in Massachusetts, US, and founded in 2018, Vincere Biosciences Inc. develops small molecule therapeutics empowered by a suite of computational tools alongside traditional biology and drug discovery expertise. In June 2023, a consortium consisting of FreeMind Investments, HanAll Biopharma, and Daewoong Pharmaceutical invested in Vincere Biosciences. The company's pipeline comprises a range of small molecules specifically designed to enhance the removal of damaged mitochondria by modulating mitochondrial quality control mechanisms, such as mitophagy.
By targeting specific enzymes involved in the mitophagy process, Vincere aims to develop small molecules that inhibit USP30, a de-ubiquitinating enzyme that slows down repair and recycling mechanisms. Additionally, the company focuses on enhancing parkin function, an E3 ligase that initiates repair or recycling processes in damaged mitochondria. These approaches hold therapeutic potential for various diseases affected by mitochondrial dysfunction, including Parkinson's disease, acute kidney disease, chronic kidney disease, and heart failure.
Current Investors
Daewoong Pharmaceutical, HanAll Biopharma, FreeMind Investments
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.vincerebio.com
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
Vincere Biosciences Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | Completed | Vincere Biosciences Inc. | - |
Displaying 1 - 1 of 1
Vincere Biosciences Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.